Passage BIO, Inc. (PASG) - Form 8-K Summary
Business Context and Reporting Period
Passage BIO, Inc., a Delaware corporation, filed this Current Report on Form 8-K on January 12, 2026. The filing updates the company's corporate presentation to disclose preliminary, unaudited financial data as of December 31, 2025. The company is listed on the Nasdaq Global Select Market under the symbol PASG.
Key Financial Metrics
- Cash Position: Approximately $46 million in cash, cash equivalents, and marketable securities as of December 31, 2025.
- Liquidity Runway: Management expects the current cash position to fund operating expenses and capital expenditure requirements into the first quarter of 2027.
- Revenue, Profit, and Margins: The filing text does not provide specific values for revenue, net income, operating margins, or cash flow for the period.
- Debt: The filing text does not provide specific values for outstanding debt.
Material Changes
This filing serves as an update to the company's corporate presentation. No specific comparative financial metrics (e.g., year-over-year changes in revenue or cash) are provided in the text of this 8-K. The primary disclosure is the updated cash balance and the revised liquidity runway estimate.
Outlook, Risks, and Unusual Items
- Management Commentary: The disclosed cash position is preliminary and unaudited. It is subject to change pending the completion of financial statements, review procedures, final adjustments, and the audit for the year ended December 31, 2025.
- Legal Disclaimer: The information in Item 2.02 and Item 7.01, including the attached corporate presentation (Exhibit 99.1), is not deemed "filed" under the Securities Exchange Act of 1934 and is not subject to the liabilities of Section 18. It will not be incorporated by reference into other filings unless expressly stated.
- Risks: The primary risk noted is the preliminary nature of the financial data, which may be adjusted upon finalization of the audit.
Investor Verification Checklist
- Verify the final audited cash, cash equivalents, and marketable securities balance in the upcoming Form 10-K for the year ended December 31, 2025.
- Confirm the actual runway for operating expenses once the 2025 financial statements are finalized.
- Review the full corporate presentation (Exhibit 99.1) for additional operational updates not detailed in the 8-K text.
- Monitor for any subsequent filings regarding capital raises or debt financing if the cash burn rate exceeds current projections.